3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
4
Prostatic Neoplasms
2
Motor Activity
2
Breast Neoplasms
2
Urologic Neoplasms
1
Testicular Neoplasms
1
Sleep Initiation and Maintenance Disorders
1
Sarcoma
1
Resectable Lung Non-Small Cell Carcinoma
1
Rectal Neoplasms
1
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
1
Penile Neoplasms
1
Pancreatic Neoplasms
1
Pain
1
Neuromuscular Diseases
1
Neoplasm Metastasis
1
Myotonic Dystrophy
1
Myositis, Inclusion Body
1
Muscular Dystrophy, Facioscapulohumeral
1
Muscular Dystrophies, Limb-Girdle
1
Muscular Atrophy, Spinal
1
Multiple Myeloma
1
Lymphoma, B-Cell
1
Lymphedema
1
Lung Neoplasms
1
Low Anterior Resection Syndrome
1
Lambert-Eaton Myasthenic Syndrome
1
Kidney Neoplasms
1
Hereditary Sensory and Motor Neuropathy
1
Guillain-Barre Syndrome
1
Interventions
pembrolizumab
14
Nivolumab
11
Ipilimumab
10
cabozantinib
6
Axitinib
6
belzutifan
5
Radiosurgery
5
atezolizumab
4
Sunitinib
4
palbociclib
3
lenvatinib
3
Surveys and Questionnaires
3
Radiotherapy
3
Pluvicto
3
Everolimus
3
Blood Specimen Collection
3
Biopsy
3
zimberelimab
2
pazopanib
2
cemiplimab
2
Therapeutics
2
Methods
2
Magnetic Resonance Spectroscopy
2
Irinotecan
2
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
2
trebananib
1
toripalimab
1
tocilizumab
1
temsirolimus
1
spartalizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Physical Therapy Modalities
×
1 year
×
Clear all
NCT05946993
2026-05-01
LIAM Mc
University College Cork
Phase NA
Active not recruiting
72 enrolled